Funding Resources
Funding Overview
Funding Strategy
Funding Opportunities |
Research
Anticonvulsant Screening
Program
Clinical Research
Counterterrorism
Epilepsy Research Web
Neural Interfaces Program
NIH Roadmap Research
Parkinson's Web
Resources for Scientists
Stem Cell Research
Translational Research
Traumatic Brain Injury
(TBI) Research
Technology Transfer
Office
NINDS is part of the
National Institutes of
Health
![]() |
Countermeasures Against Chemical Threats (CounterACT) Advanced Development Cooperative Agreements (U01)
Release Date: October 2, 2007
Announcement Number: RFA-NS-08-003
Application Receipt Date:
December 10, 2007
Letter of Intent Date: November 9, 2007
Funding Contact: David Jett, Ph.D.
Program Area: Technology Development
Also See:
http://grants.nih.gov/grants/guide/notice-files/NOT-NS-08-007.html
Brief Description:
The NIH invites applications for Countermeasures Against Chemical Threats (CounterACT) Advanced Development Cooperative Agreements
(U01s). The overall mission of the CounterACT Research Network is to develop new and improved medical countermeasures against
chemical threats (see http://www.ninds.nih.gov/funding/research/counterterrorism/index.htm). These include pulmonary agents
such as chlorine, industrial chemicals such as cyanide, and nerve agents such as sarin. Unlike the previous CounterACT Funding
Opportunity Announcements (FOAs), sulfur mustard research will not be supported by this announcement, research on diagnostic
technologies will not be supported, and the focus will be on therapies that can be used after exposure to a chemical threat
as opposed to pre-exposure prophylactic treatments. The expected outcome of each of these accelerated three-year projects
is a lead compound or validated model for screening relevant therapeutics.
Choose an option to view additional funding announcements |
New Announcements | Research Area | RFAs Only | PAs Only | RFPs Only | Notices Only | Supplements Only | All Announcements | Archives |